Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
Andrea Cipriani(Oxford Health NHS Foundation Trust), Corrado Barbui(University of Verona), Julian P. T. Higgins(University of Bristol), Atsuo Nakagawa(Keio University), Rachel Churchill(Kleijnen Systematic Reviews (United Kingdom)), Hugh McGuire(Cochrane), John Geddes(University of Oxford), Toshi A. Furukawa(Kyoto University), Georgia Salanti(University of Bern), Norio Watanabe(University College London), Ichiro M Omori(Nagoya City University), Michele Tansella(University of Verona)
Cited by 1,659
Related Papers
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
|Annals of Internal Medicine|2015|8.2k
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
|Journal of Clinical Epidemiology|2010|3.8k
Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis
|The Lancet|2018|3.5k
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
|The Lancet|2013|2.5k
Graphical Tools for Network Meta-Analysis in STATA
|PLoS ONE|2013|2.5k